Found: 42
Select item for more details and to access through your institution.
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1405361
- By:
- Publication type:
- Article
BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1390116
- By:
- Publication type:
- Article
Cyclopamine-Paclitaxel-Containing Nanoparticles: Internalization in Cells Detected by Confocal and Super-Resolution Microscopy.
- Published in:
- ChemPlusChem, 2015, v. 80, n. 9, p. 1380, doi. 10.1002/cplu.201500156
- By:
- Publication type:
- Article
Click Reaction as a Tool to Combine Pharmacophores: The Case of Vismodegib.
- Published in:
- ChemPlusChem, 2015, v. 80, n. 6, p. 938, doi. 10.1002/cplu.201402435
- By:
- Publication type:
- Article
Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways.
- Published in:
- International Journal of Cancer, 2001, v. 92, n. 4, p. 583, doi. 10.1002/ijc.1221
- By:
- Publication type:
- Article
Bcl-2 family inhibitors sensitize human cancer models to therapy.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 7, p. 1, doi. 10.1038/s41419-023-05963-1
- By:
- Publication type:
- Article
Role of Chk1 in the differentiation program of hematopoietic stem cells.
- Published in:
- Cellular & Molecular Life Sciences, 2010, v. 67, n. 10, p. 1713, doi. 10.1007/s00018-010-0274-1
- By:
- Publication type:
- Article
Predictive modeling of gene expression regulation.
- Published in:
- BMC Bioinformatics, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s12859-021-04481-1
- By:
- Publication type:
- Article
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 5, p. 3049, doi. 10.3390/ijms25053049
- By:
- Publication type:
- Article
Recent Insights into Mucinous Ovarian Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 6, p. 1569, doi. 10.3390/ijms19061569
- By:
- Publication type:
- Article
Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 6, p. 779, doi. 10.1002/(SICI)1097-0215(19960611)66:6<779::AID-IJC12>3.0.CO;2-Z
- By:
- Publication type:
- Article
In vivo anti-tumor activity of synthetic ether lipids is not enhanced by pharmacological modulation of tumor lipid composition.
- Published in:
- International Journal of Cancer, 1994, v. 59, n. 4, p. 580, doi. 10.1002/ijc.2910590423
- By:
- Publication type:
- Article
Onvansertib and paclitaxel combined in platinum-resistant ovarian carcinomas.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221095064
- By:
- Publication type:
- Article
The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02459-2
- By:
- Publication type:
- Article
An integrative functional genomics approach reveals EGLN1 as a novel therapeutic target in KRAS mutated lung adenocarcinoma.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Lack of Efficacy: When Opioids Do Not Achieve Analgesia from the Beginning of Treatment in Cancer Patients.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 10337, doi. 10.2147/CMAR.S211818
- By:
- Publication type:
- Article
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01196-x
- By:
- Publication type:
- Article
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Triple Negative Breast Cancers Have a Reduced Expression of DNA Repair Genes.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0066243
- By:
- Publication type:
- Article
The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 191, doi. 10.1111/bjh.19218
- By:
- Publication type:
- Article
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs.
- Published in:
- Scientific Reports, 2016, p. 39217, doi. 10.1038/srep39217
- By:
- Publication type:
- Article
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919839543
- By:
- Publication type:
- Article
Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919839543
- By:
- Publication type:
- Article
HPLC-MS/MS method for quantitative determination of the novel dual inhibitor of FGF and VEGF receptors E-3810 in tumor tissues from xenograft mice and human biopsies.
- Published in:
- Journal of Mass Spectrometry, 2014, v. 49, n. 1, p. 19, doi. 10.1002/jms.3305
- By:
- Publication type:
- Article
Impact of the interplay between stemness features, p53 and pol iota on replication pathway choices.
- Published in:
- Nucleic Acids Research, 2021, v. 49, n. 13, p. 7457, doi. 10.1093/nar/gkab526
- By:
- Publication type:
- Article
Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.903536
- By:
- Publication type:
- Article
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.903016
- By:
- Publication type:
- Article
Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticles.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1128582
- By:
- Publication type:
- Article
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4309, doi. 10.3390/cancers15174309
- By:
- Publication type:
- Article
Combinations of ATR, Chk1 and Wee1 Inhibitors with Olaparib Are Active in Olaparib Resistant Brca1 Proficient and Deficient Murine Ovarian Cells.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1807, doi. 10.3390/cancers14071807
- By:
- Publication type:
- Article
CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3477, doi. 10.3390/cancers13143477
- By:
- Publication type:
- Article
Impact of ERCC1, XPF and DNA Polymerase β Expression on Platinum Response in Patient-Derived Ovarian Cancer Xenografts.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2398, doi. 10.3390/cancers12092398
- By:
- Publication type:
- Article
Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 672, doi. 10.3390/cancers12030672
- By:
- Publication type:
- Article
Platinum Resistance in Ovarian Cancer: Role of DNA Repair.
- Published in:
- Cancers, 2019, v. 11, n. 1, p. 119, doi. 10.3390/cancers11010119
- By:
- Publication type:
- Article
Is PDGFR an important target for E-3810?
- Published in:
- Journal of Cellular & Molecular Medicine, 2012, v. 16, n. 11, p. 2838, doi. 10.1111/j.1582-4934.2012.01601.x
- By:
- Publication type:
- Article
U2OS cells lacking Chk1 undergo aberrant mitosis and fail to activate the spindle checkpoint.
- Published in:
- Journal of Cellular & Molecular Medicine, 2009, v. 13, n. 8a, p. 1565, doi. 10.1111/j.1582-4934.2008.00362.x
- By:
- Publication type:
- Article
Evaluation of safety and efficacy of tivantinib in the treatment of inoperable or recurrent non-small-cell lung cancer.
- Published in:
- Cancer Management & Research, 2013, v. 5, p. 15, doi. 10.2147/CMAR.S29995
- By:
- Publication type:
- Article
Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0145647
- By:
- Publication type:
- Article
Combining Ibrutinib with Chk1 Inhibitors Synergistically Targets Mantle Cell Lymphoma Cell Lines.
- Published in:
- 2018
- By:
- Publication type:
- journal article
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.
- Published in:
- Molecular Cancer, 2017, v. 16, p. 1, doi. 10.1186/s12943-017-0662-3
- By:
- Publication type:
- Article